SCHEMBL12166209

SCHEMBL12166209

CC(C)(Oc1ccc(NC(=O)c2ccc(Cl)cc2)cc1)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 5/20 0.69
MEN1 O00255 5/20 0.69
KMT2A Q03164 5/20 0.69
CYP1A2 P05177 3/20 0.69
CYP3A4 P08684 3/20 0.69
CYP2C19 P33261 3/20 0.69
CYP2D6 P10635 2/20 0.69
MAPT P10636 2/20 0.69
PPARG P37231 3/20 0.69
FABP2 P12104 2/20 0.69
SLC22A12 Q96S37 1/20 0.69
SMN1; SMN2 Q16637 4/20 0.64
ALDH1A1 P00352 1/20 0.64
PPARD Q03181 1/20 0.64
NPC1 O15118 4/20 0.62
RAB9A P51151 3/20 0.62
ENPP3 O14638 3/20 0.56
ENPP1 P22413 3/20 0.56
TRPV1 Q8NER1 3/20 0.56
CYP2C9 P11712 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16265332 0.89 PGR (0.60) PPARAMEN1KMT2ACYP1A2CYP3A4
SCHEMBL9130742 0.88 PPARA (0.59) PPARAMEN1KMT2ACYP1A2CYP3A4
SCHEMBL16743652 0.87 NPC1 (0.64) PPARAMEN1KMT2ACYP1A2CYP3A4
SCHEMBL16743452 0.87 RAB9A (0.71) MEN1KMT2ACYP1A2CYP3A4CYP2C19
SCHEMBL13945767 0.87 NPC1 (0.68) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL16265333 0.85 PPARA (0.54) PPARAMEN1KMT2ACYP1A2CYP3A4
Clofibric Acid SCHEMBL102826 0.83 PPARA (1.00) PPARAMEN1KMT2ACYP1A2CYP3A4
SCHEMBL6558005 0.83 PPARA (0.69) PPARAMEN1KMT2ACYP1A2CYP3A4
Clofibric Acid SCHEMBL2227936 0.83 PPARA (1.00) PPARAMEN1KMT2ACYP1A2CYP3A4
Fenofibric Acid SCHEMBL16377 0.82 PPARA (1.00) PPARAMEN1KMT2ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120232120-A1 AMINO ACID AMIDES OF PHENOXYBUTYRIC ACID DERIVATIVES LALEZARI IRAJ (US) 2012-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120232120-A1 AMINO ACID AMIDES OF PHENOXYBUTYRIC ACID DERIVATIVES SLC1A5, BCAT2, PAH PPARA 525/4885MEN1 1180/4885KMT2A 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.